Radeva-Ilieva, M., Stoeva, S., Hvarchanova, N., & Georgiev, K
These findings resulted in a boxed warning in the prescribing information for Ozempic, Wegovy, and Rybelsus, the strongest warning the FDA can require
An important note: In August 2025, the Trump Administration said it is considering a pilot program that would cover weight-loss drugs under Medicare for five years
Zhang Y, Gemeinhart RA: Improving matrix metalloproteinase-2 specific response of a hydrogel system using electrophoresis
By the 24-week mark, levels decreased by 2.02% (22.07 mmol/mol), and by 2.16% (23.59 mmol/mol) at 36 weeks, compared to no significant changes in the control group
The cream may eventually change diabetes management